SCHEMBL3820231

SCHEMBL3820231

CC(c1nc2ccc(C(N)=O)cc2c(=O)n1C)N1CCN(S(=O)(=O)c2ccc(Br)cc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ GBA1 P04062 1/20 0.38
▸ GPR183 P32249 1/20 0.38
▸ F10 P00742 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ NOD1 Q9Y239 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ HPD P32754 1/20 0.38
▸ PKM P14618 2/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ NSD2 O96028 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3819862 0.91 S1PR1 (0.45) L3MBTL1GBA1SMN1; SMN2HTTLMNA
SCHEMBL3820236 0.90 CFTR (0.45) ALDH1A1GBA1GAANPC1RAB9A
SCHEMBL3817090 0.89 PKM (0.42) L3MBTL1GBA1GPR183GAAPKM
SCHEMBL3825392 0.87 PKM (0.39) ALDH1A1L3MBTL1GBA1GPR183GAA
SCHEMBL3824315 0.86 PKM (0.40) L3MBTL1GBA1GPR183GAAPKM
SCHEMBL15457092 0.85 PKM (0.43) ALDH1A1L3MBTL1GBA1GPR183GAA
SCHEMBL15457299 0.85 GBA1 (0.47) ALDH1A1GBA1GAASMN1; SMN2NPC1
SCHEMBL3820657 0.84 GAA (0.47) ALDH1A1GBA1GAAHTTPKM
SCHEMBL3822489 0.84 PKM (0.47) L3MBTL1GBA1GAANPC1HTT
SCHEMBL15457174 0.84 CFTR (0.46) ALDH1A1L3MBTL1GBA1GPR183SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 — — US disclosed
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 — — US disclosed
US-8642609-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-02-04 — — US disclosed
EP-1646615-B1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2009-08-26 — — EP disclosed
EP-1646615-B1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMA (US) 2009-08-26 — — EP disclosed
EP-1646615-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals Incorporated (US) 2006-04-19 — — EP disclosed
US-20050059687-A1 Modulators of ATP-Binding Cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2005-03-17 — — US disclosed
WO-2004111014-A1 PYRIMIDINE DERIVATIVES AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-12-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059687-A1 Modulators of ATP-Binding Cassette transporters CFTR, ABCB1, ABCC2 ALDH1A1 1892/4885L3MBTL1 3800/4885GBA1 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback